The Latest Breaking News from Omicron

Immunome Inc (NASDAQ:IMNM) has announced that its cocktail (IMM-BCP-01) retained activity against the BA.4/5 and BA.2.12.1 subvariants in lab testing.  IMM-BCP-01 is currently in Phase 1b testing in patients infected with SARS-CoV-2 and in locations where the predominant variants are BA.2.12.1, BA.4, BA.5, and BA.2. Related: Immunome Shares Rise After Publishing Positive COVID-19 Antibody…

Australia is expected to follow other parts of the world in expanding eligibility for a fourth COVID-19 vaccine dose to the wider population, with the Prime Minister saying the pandemic "isn't over" while encouraging eligible Australians to get their booster shots.

The TGA’s ‘provisional determination’ for two vaccines comes as BA.4 and BA.5 subvariants drive new wave of Covid cases

Fainting and fatigue may signal onset of variant, experts say

‘Even when testing was at a different point, it has always been an underestimate’

Experts have warned Brits' summer holiday plans could be hampered amid a rise in Covid cases thanks to the spread of Omicron sub-variants in recent weeks

LOS ANGELES — Are people in your life being infected with the coronavirus, even after being caught up in an earlier wave?

Infections are increasing across the UK, in a wave driven by the Omicron BA.4 and BA.5 variants

More than two years into the pandemic, SARS-CoV-2, the virus that causes COVID-19, continues to challenge us. Its ability to rapidly mutate has seen the evolution of increasingly infectious variants that are getting better at hiding from our immune response.